{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:56:48Z","timestamp":1794477408790,"version":"4.9.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>\n                    Post-marketing reports in dogs treated with\n                    <jats:italic>bedinvetmab<\/jats:italic>\n                    (Librela\u2122, Zoetis), the first anti-nerve growth factor (NGF) monoclonal antibody approved for canine osteoarthritis pain, include musculoskeletal, autonomic, and neurological events. Existing interpretations address these domains separately or focus on the limitations of pharmacovigilance systems. Here, we propose a complementary, integrative interpretation: at least some of these events may share an on-target component arising from systemic NGF sequestration\u2014an iatrogenic state of neurotrophic withdrawal. The evidence derives mainly from\n                    <jats:italic>bedinvetmab<\/jats:italic>\n                    , but the recent authorization of a second canine anti-NGF agent,\n                    <jats:italic>izenivetmab<\/jats:italic>\n                    (Lenivia\u2122, Zoetis), raises a testable class-level safety question. Drawing on neurotrophin biology, human anti-NGF development programs, regulatory data, and the most recent evidence linking somatosensory innervation to skeletal repair, we outline how reduced NGF-mediated trophic support might affect joint protection and load adaptation\/fracture repair, autonomic regulation, and central neuronal maintenance, particularly in geriatric animals. We set out the predictions that distinguish this account from unrelated background disease, and the studies that would test them.\n                  <\/jats:p>","DOI":"10.3389\/fvets.2026.1776920","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:29:06Z","timestamp":1789104546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A neurotrophic withdrawal hypothesis for multisystem adverse events associated with anti-NGF therapy for canine osteoarthritis pain"],"prefix":"10.3389","volume":"13","author":[{"given":"Giovanni","family":"Federico","sequence":"first","affiliation":[{"name":"Department of Education, Psychology and Communication, Suor Orsola Benincasa University","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Ilardi","sequence":"additional","affiliation":[{"name":"Inmates Ward, Department of Internal Medicine, Antonio Cardarelli Hospital","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Elia","sequence":"additional","affiliation":[{"name":"Department of Education, Psychology and Communication, Suor Orsola Benincasa University","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Chieffi","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu Rev Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1359-6101(98)00003-3","article-title":"Pleiotropic functions of neurotrophins in development","volume":"9","author":"Tessarollo","year":"1998","journal-title":"Cytokine Growth Factor Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","article-title":"Neurotrophin-regulated signalling pathways","volume":"361","author":"Reichardt","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signalling pathways","volume":"4","author":"Chao","year":"2003","journal-title":"Nat Rev Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/art.39492","article-title":"When is osteonecrosis not osteonecrosis? Adjudication of reported serious adverse joint events in the tanezumab clinical development program","volume":"68","author":"Hochberg","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B6","first-page":"S85","article-title":"Current status of nerve growth factor antibodies for the treatment of osteoarthritis pain","volume":"35","author":"Miller","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B7","unstructured":"Smith\n              J\n            \n            \n              Hugunin\n              K\n            \n          \n          Standard Adverse Event Pharmacovigilance Review for Librela\n          \n          2024"},{"key":"B8","unstructured":"Dear Veterinarian Letter Notifying Veterinarians About Adverse Events Reported in Dogs Treated with Librela (Bedinvetmab Injection)\n          \n          2024"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1581490","DOI":"10.3389\/fvets.2025.1581490","article-title":"Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)","volume":"12","author":"Farrell","year":"2025","journal-title":"Front Vet Sci."},{"key":"B10","unstructured":"Results of in-Depth Assessment of Selected Adverse Events for \u201cLibrela Solution for Injection for Dogs\u201d\n          \n          2026"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1640217","DOI":"10.3389\/fvets.2025.1640217","article-title":"Rapidly progressive osteoarthritis (RPOA) in companion animals treated with bedinvetmab (Librela\u2122): an expected pathophysiological phenomenon or a cause for concern?","volume":"12","author":"Mobasheri","year":"2025","journal-title":"Front Vet Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1628681","DOI":"10.3389\/fvets.2025.1628681","article-title":"Commentary: musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)","volume":"12","author":"Brunke","year":"2025","journal-title":"Front Vet Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/cdd.2013.22","article-title":"ProNGF\\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice","volume":"20","author":"Tiveron","year":"2013","journal-title":"Cell Death Differ."},{"key":"B14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/BST0340607","article-title":"Mechanisms of neurotrophin receptor signalling","volume":"34","author":"Zampieri","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"B15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature02319","article-title":"Sortilin is essential for proNGF-induced neuronal cell death","volume":"427","author":"Nykjaer","year":"2004","journal-title":"Nature."},{"key":"B16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jbior.2014.11.003","article-title":"NGF and proNGF: regulation of neuronal and neoplastic responses through receptor signaling","volume":"58","author":"Bradshaw","year":"2015","journal-title":"Adv Biol Regul"},{"key":"B17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/ijms18030599","article-title":"ProNGF, but not NGF, switches from neurotrophic to apoptotic activity in response to reductions in TrkA receptor levels","volume":"18","author":"Ioannou","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/cells10081983","article-title":"Effects of reactive oxygen and nitrogen species on TrkA expression and signalling: implications for proNGF in aging and Alzheimer's disease","volume":"10","author":"Kropf","year":"2021","journal-title":"Cells."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1241420","DOI":"10.3389\/fnmol.2023.1241420","article-title":"Age-induced nitrative stress decreases retrograde transport of proNGF via TrkA and increases proNGF retrograde transport and neurodegeneration via p75NTR","volume":"16","author":"Kropf","year":"2023","journal-title":"Front Mol Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/nau.20837","article-title":"Neural control of the lower urinary tract: peripheral and spinal mechanisms","volume":"29","author":"Birder","year":"2010","journal-title":"Neurourol Urodyn."},{"key":"B21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/j.2040-4603.2015.tb00596.x","article-title":"Neural control of the lower urinary tract","volume":"5","author":"de Groat","year":"2015","journal-title":"Compr Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1201\/b18585-3","article-title":"Integrated physiology of the lower urinary tract","author":"Yoshimura","year":"2015","journal-title":"Textbook of the Neurogenic Bladder"},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-540-79090-7_4","article-title":"Afferent nerve regulation of bladder function in health and disease","volume":"194","author":"de Groat","year":"2009","journal-title":"Handb Exp Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"R534","DOI":"10.1152\/ajpregu.00367.2009","article-title":"Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function","volume":"298","author":"Schnegelsberg","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-3-642-16499-6_19","article-title":"Neuropeptides in lower urinary tract function","volume":"202","author":"Arms","year":"2011","journal-title":"Handb Exp Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2174\/157015911798376253","article-title":"Neurotrophins in the lower urinary tract: becoming of age","volume":"9","author":"Frias","year":"2011","journal-title":"Curr Neuropharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2019.8044","article-title":"Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial","volume":"322","author":"Schnitzer","year":"2019","journal-title":"JAMA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/annrheumdis-2015-208913","article-title":"Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model","volume":"76","author":"LaBranche","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1344359","DOI":"10.3389\/fcdhc.2024.1344359","article-title":"Charcot neuro-osteoarthropathy: a review of key concepts and an evidence-based surgical management algorithm","volume":"5","author":"Argyropoulos","year":"2024","journal-title":"Front Clin Diabetes Healthc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E3632","DOI":"10.1073\/pnas.1701054114","article-title":"NGF-TrkA signaling in sensory nerves is required for skeletal adaptation to mechanical loads in mice","volume":"114","author":"Tomlinson","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.joca.2014.10.005","article-title":"Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies","volume":"23","author":"Hochberg","year":"2015","journal-title":"Osteoarthr Cartil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jsap.13566","article-title":"2022 WSAVA guidelines for the recognition, assessment and treatment of pain","volume":"64","author":"Monteiro","year":"2023","journal-title":"J Small Anim Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"eadr9608","DOI":"10.1126\/science.adr9608","article-title":"Mapping somatosensory afferent circuitry to bone identifies neurotrophic signals required for fracture healing","volume":"391","author":"Xu","year":"2026","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11853","DOI":"10.1073\/pnas.1003317107","article-title":"Fgf-9 is required for angiogenesis and osteogenesis in long bone repair","volume":"107","author":"Behr","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1172\/JCI128428","article-title":"Fracture repair requires TrkA signaling by skeletal sensory nerves","volume":"129","author":"Li","year":"2019","journal-title":"J Clin Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/jor.22892","article-title":"Analgesia via blockade of NGF\/TrkA signaling does not influence fracture healing in mice","volume":"33","author":"Rapp","year":"2015","journal-title":"J Orthop Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1100\/tsw.2011.26","article-title":"Spinal cord injury and bladder dysfunction: new ideas about an old problem","volume":"11","author":"Cruz","year":"2011","journal-title":"ScientificWorldJournal."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12917-015-0628-x","article-title":"Measurements of C-reactive protein (CRP) and nerve-growth-factor (NGF) concentrations in serum and urine samples of dogs with neurologic disorders","volume":"12","author":"Kordass","year":"2016","journal-title":"BMC Vet Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron."},{"key":"B40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcpa.2005.01.001","article-title":"Immunohistochemical and ultrastructural findings related to the blood\u2013brain barrier in the blood vessels of the cerebral white matter in aged dogs","volume":"133","author":"Morita","year":"2005","journal-title":"J Comp Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/01652176.2025.2450041","article-title":"The canine blood-brain barrier in health and disease: focus on brain protection","volume":"45","author":"Bassalo","year":"2025","journal-title":"Vet Q."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1572286","DOI":"10.3389\/fvets.2025.1572286","article-title":"Blood\u2013brain barrier permeability changes in dogs with suspected canine cognitive dysfunction using magnetic resonance imaging subtraction enhancement analysis","volume":"12","author":"Merbl","year":"2025","journal-title":"Front Vet Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1038\/s41598-024-52324-9","article-title":"Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs","volume":"14","author":"Enomoto","year":"2024","journal-title":"Sci Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1073858410381532","article-title":"Sink hypothesis and therapeutic strategies for attenuating A\u03b2 levels","volume":"17","author":"Zhang","year":"2011","journal-title":"Neuroscientist."},{"key":"B45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2460\/javma.25.09.0578","article-title":"Dysmetabolism of the nerve growth factor pathway in the aging brain plays a pivotal role in cognitive decline","volume":"264","author":"Dewey","year":"2026","journal-title":"J Am Vet Med Assoc."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/ph14101057","article-title":"Epilepsy in neurodegenerative diseases: related drugs and molecular pathways","volume":"14","author":"Cano","year":"2021","journal-title":"Pharmaceuticals."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/j.1460-9568.1995.tb01143.x","article-title":"Immunocytochemical localization of TrkA receptors in chemically identified subgroups of adult rat sensory neurons","volume":"7","author":"Averill","year":"1995","journal-title":"Eur J Neurosci."},{"key":"B48","unstructured":"Lenivia (Izenivetmab): Veterinary Medicinal Product Information\n          \n          2025"},{"key":"B49","unstructured":"Lenivia: Summary of Opinion (Initial Authorisation).\n          \n          2025"},{"key":"B50","unstructured":"Lenivia (Izenivetmab), DIN 02561816: Product Monograph\/Veterinary Labelling\n          \n          2025"},{"key":"B51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/toxsci\/kfx089","article-title":"From the cover: evaluation of the effects of tanezumab, a monoclonal antibody against nerve growth factor, on the sympathetic nervous system in adult cynomolgus monkeys (Macaca fascicularis): a stereologic, histomorphologic, and cardiofunctional assessment","volume":"158","author":"Belanger","year":"2017","journal-title":"Toxicol Sci."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1776920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:41:21Z","timestamp":1790689281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1776920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":51,"alternative-id":["10.3389\/fvets.2026.1776920"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1776920","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1776920"}}